Results 21 to 30 of about 204,272 (330)
Angiotensin II and COVID-19. Secrets of interactions
Российский кардиологический журнал, 2020 The article describes current data on the relationship of renin-angiotensin system and related drugs with the risk of COVID-19 infection and its outcomes.
A. O. Konradi, A. O. Nedoshivin
doaj +1 more source
SGLT2 Inhibitors for Nephrologists
European Medical Journal Nephrology, 2022 Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are the mainstay of therapy for the prevention of progressive renal damage in diabetic and non-diabetic kidney diseases, especially glomerulonephritides.
Mufti Baleegh-ur-Raheem Mahmood +1 more
doaj +1 more source
Journal of Cardiac Arrhythmias, 2020 Initially reported in China at the end of 2019, the coronavirus pandemic has now reached an international scale with more than1.5 million cases worldwide and more than 80,000 deaths by April 8th of this year.
Neiberg de Alcantara Lima +4 more
doaj +1 more source
Klinicist, 2021 In the development of renocardial relationships in chronic kidney disease, an important role is given to the activation of the renin-angiotensin-aldosterone system (RAAS), as the main component of the progression and development of cardiovascular ...
I. T. Murkamilov
doaj +1 more source
The use of angiotensin-converting enzyme inhibitors in general medicine
South African Family Practice, 2012 Angiotensin-converting enzyme (ACE) inhibitors are a class of drugs commonly used in the management of hypertension, congestive heart failure, cerebrovascular disease, stable coronary heart disease and diabetes-associated nephropathy.
M.L.I. Mashitisho
doaj +1 more source
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension?
Current Cardiology Reports, 2020 Purpose of Review Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are commonly used anti-hypertensive medications in a number of clinical settings. They are often used interchangeably, but we pose the provocative question as to
Jeffrey M. Turner, R. Kodali
semanticscholar +1 more source
Angiotensin-converting Enzyme Inhibitors-induced Angioedema
Journal of Cardiovascular Emergencies, 2018 Angiotensin-converting enzyme inhibitors (ACEI) are widely used drugs nowadays in treating patients diagnosed with cardiovascular disorders. We present two consecutive cases of acquired angioedema caused by the administration of enalapril and lisinopril ...
Chiriac Anca +3 more
doaj +1 more source
Pharmacotherapy and analysis of gaseous mediators in hypertensive patients
Revista da Escola de Enfermagem da USP, 2015 OBJECTIVE To evaluate the effect of using antihypertensive classes of drugs of the calcium channel antagonists and inhibitors of angiotensin-converting enzyme in plasma concentrations of hydrogen sulfide and nitric oxide in patients with hypertension ...
Letícia Palota Eid +4 more
doaj +1 more source
EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE
Рациональная фармакотерапия в кардиологии, 2015 Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease.
Jose Lopez-Sendon +10 more
doaj +3 more sources
Postoperative angioedema induced by angiotensin-converting enzyme inhibitor: case report [PDF]
Revista Brasileira de Anestesiologia, 2019 Background and objectives: Angioedema is a potentially fatal condition that may occur at any time in the perioperative period. It may result from histamine release, hypersensitivity reaction to drugs, or be triggered by bradykinin, in non-allergic ...
Flora Margarida Barra Bisinotto +4 more
doaj +3 more sources